Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
A landmark Nature study has mapped how bladder cancer spreads — and the findings are reshaping how we think about treatment. Researchers from Fred Hutch and the University of Washington reconstructed tumor evolution in 20 patients and found that early metastatic tumors act as launchpads for further spread. The work also shows that blood-based DNA tests could non-invasively track how tumors evolve into more aggressive forms.
A groundbreaking study published in Nature has mapped the evolutionary landscape of metastatic bladder cancer, offering new clues about how the disease spreads and how it might be better treated. Researchers from Fred Hutch Cancer Center and the University of Washington reconstructed the tumor histories of 104 tumors from 20 patients using a first-of-its-kind rapid autopsy program — revealing that the earliest metastatic tumor likely serves as the primary source for widespread disease progression.
The team found that metastases don't just settle — they seed new metastases, fueling the spread of increasingly aggressive cancer subtypes from site to site. The study also identified distinct differences between bladder cancer subtypes, including how each develops metastasis and responds to treatment.
Key Takeaways:
Why it matters: Metastasis is the leading cause of death in bladder cancer. By understanding the order and mechanics of spread, clinicians may be able to intervene earlier — and more precisely — before the disease becomes unmanageable.
